A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal Cancer

PHASE2TerminatedINTERVENTIONAL
Timeline

Start Date

June 30, 2002

Conditions
Colorectal NeoplasmsDiarrhea
Interventions
DRUG

Investigational drug

DRUG

Irinotecan

DRUG

5-fluorouracil

DRUG

Leucovorin

Trial Locations (28)

11733

Research Center, East Setauket

17605

Research Center, Lancaster

27216

Research Center, Burlington

27834

Research Center, Greenville

29403

Research Center, Charleston

29406

Research Center, Charleston

32207

Research Center, Jacksonville

34652

Research Center, New Port Richey

38138

Research Center, Germantown

43701

Research Center, Zanesville

48824

Research Center, East Lansing

49085

Research Center, Saint Joseph

53215

Research Center, Milwaukee

55455

Research Center, Minneapolis

64507

Research Center, Saint Joseph

70115

Research Center, New Orleans

72205

Research Center, Little Rock

75230

Research Center, Dallas

89106

Research Center, Las Vegas

90057

Research Center, Los Angeles

92801

Research Center, Anaheim

94520

Research Center, Concord

95020

Research Center, Gilroy

04074-9308

Research Center, Scarborough

01201

Research Center, Pittsfield

11768-2364

Research Center, Northport

19140-5189

Research Center, Philadelphia

53792-2454

Research Center, Madison

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Celgene Corporation

INDUSTRY